By Adam Bonislawski
Researchers at the University of Pittsburgh Cancer Institute have identified a panel of ten serum protein markers that could be used in risk assessment and the early detection of lung cancer.
By Adam Bonislawski
Biodesix said this week that it is collaborating with pharma firm Kadmon on a 620-patient Phase III clinical trial of that company's reversible tyrosine kinase inhibitor KD019.
Dako, Amgen Ink CDx Deal for Undisclosed Oncologic
Dako and Amgen announced they will partner to develop a companion diagnostic for an undisclosed oncology drug that Amgen is currently advancing in clinical trials.
Integrated Diagnostics announced this week the appointment of Donald Seaton as its chief financial officer and James Garner as its chief business officer.
By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Integrated Diagnostics today announced it has secured $10 million in a third tranche of its Series A financing round.
